Maine paves the way for a referendum challenging the legalization of cannabis

Nearly a decade after voters approved the legalization of cannabis in Maine, a new political battle looms. State officials have approved a referendum initiative aimed at reversing much of the framework adopted in 2016 for adult recreational use, opening the way for prohibitionist activists to start gathering signatures for a possible vote in 2026.

The proposal, officially titled «An Act to Amend the Cannabis Legalization Act and the Medical Use of Cannabis Act in Maine,» was approved by the Secretary of State's office in early December.

Supporters of this measure must now collect at least 67,682 valid signatures before February 2, 2026, so that it can be put to the vote. If it is finally approved by the electorate, the changes will not come into force until January 1, 2028.

What the repeal initiative would change

Basically, the initiative aims to dismantle the sale of recreational cannabis in the state by deleting key sections of the existing law. Licensed recreational retailing would effectively disappear, destroying a market that has grown steadily since its inception.

However, the proposal does not amount to a complete return to prohibition. Adult possession of up to 2.5 ounces of cannabis would remain legal for people aged 21 and over. Medical cannabis would also continue to be permitted, including sale through dispensaries and limited home cultivation for patients.

One notable setback concerns personal cultivation rights. While home cultivation for medical purposes would remain legal, the initiative would repeal the provisions allowing adults to grow cannabis at home for non-medical purposes, one of the pillars of the 2016 reform.

Supporters invoke regulation and public health

The revised initiative is supported by personalities closely associated with Maine's former prohibitionist leaders, including allies of the former Republican Governor Paul LePage. Madison Carey, who helped draft both the original and revised versions of the proposal, presents this initiative as a response to what she sees as a lack of control.

«Cannabis needs to be regulated,» she told Marijuana Moment, linking his position to his personal experience of detoxification after opioid abuse. «My hope is simply to raise public awareness of the potential dangers of unregulated use.»

Supporters say that the visibility of licensed retail stores and their widespread access have fueled public concerns, particularly regarding youth exposure and community impact.

As well as abolishing sales to adults, the initiative would also reshape the medical cannabis program. It requires the creation of a state-run testing system, obliging dispensaries and caregivers to submit products to safety assessments before distribution.

Under the proposal, cannabis products would have to meet defined standards for contamination and accuracy of labeling. Regulators would also be tasked with establishing a tracking system from seed to sale, The system monitors plants from cultivation to retail sale or disposal, but does so by group rather than by individual plant marking.

The director of Office of Cannabis Policy would see its mission refocused on public health, with an explicit emphasis on protecting minors while guaranteeing patients access to «high-quality, effective and affordable» medical products.

Industry and reform advocates fight back

Critics of the initiative warn that repealing the legalization of adult use would have serious economic consequences. Representative David Boyer, who helped lead the victorious 2016 campaign, urged voters to reject the petition.

«Don't give up on the progress Maine has made, refuse to sign this misguided repeal initiative,» he said, arguing that the legal cannabis industry now outstrips traditional industries in terms of job creation and income.

Supporters of reform also point to a paradox at the heart of the proposal: abolishing licensed retailers would dismantle the regulatory infrastructure designed to replace the illicit market and manage public health risks.